Role of cell cholesterol in modulating vincristine uptake and resistance

• Published in: International journal of cancer Vol. 55; no. 4; p. 667
• Main Authors: Pallarés-Trujillo, J, Domènech, C, Grau-Oliete, M R, Rivera-Fillat, M P
• Format: Journal Article
• Language: English
• Published: United States 21.10.1993
• Subjects: Animals; Cholesterol - pharmacology; Drug Resistance; Leukemia L5178 - metabolism; Mice; Tumor Cells, Cultured; Vincristine - metabolism
• ISSN: 0020-7136
• DOI: 10.1002/ijc.2910550426

The relationship between cell-membrane permeability to vincristine and cholesterol/phospholipid levels was studied in L5178Y murine leukemic lymphoblasts and in 2 multidrug-resistant cell sublines, VCR/P60 and VCR/P200, which expressed increasing levels of vincristine resistance. The uptake of 3H-vincristine was measured in all cell lines and in cholesterol-depleted and -reloaded L5178Y and VCR/P200 cells. The initial rate of drug entry in resistant cells was lower than that measured in the parental cell line and it decreased as the relative resistance increased. An increment of cholesterol content, characterized in resistant cells, was directly proportional to the relative resistance to vincristine. Cholesterol depletion in both sensitive and resistant cells resulted in an increase in the rate of vincristine uptake, which reverted to the respective basal levels when each cell line was cholesterol-reloaded. The rate of drug uptake was inversely correlated with the molar ratio of cholesterol to phospholipids. Although both VCR/P cell sublines, but not the sensitive parental cells, expressed the P-glycoprotein in their plasma membrane, there were no differences in drug efflux and retention between resistant and parental cells. These results indicate that cholesterol modulates the permeation of vincristine through the plasma membrane and strongly suggest that increased levels of cholesterol/phospholipid account for the lower drug accumulation and greater resistance in these multidrug-resistant cells.